Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...

Amy Sheng (left) is Head of the CRO Program at Sino Biological US Inc. (PA, USA), and has expertise in cell, molecular biology, immunology and biochemistry. In this interview, Amy discusses the ...

“BIOHAZARDS AT HARVARD,” warns the cover of the June 8, 1976 issue of the Boston Phoenix. “Scientists are on the brink of undertaking revolutionary genetic research which creates new life forms,” the ...

In September, David Baltimore — the scientist who discovered reverse transcriptase, a breakthrough often described as one of ...

Recombinant antibody technology has been leveraged to mitigate a range of common problems associated with hybridoma platforms, helping to facilitate the development of an entirely new class of ...

The rDNA debate was initiated by the molecular biologists leading the research, and within a year expanded to include the public. Fourteen key participants representing molecular biologists, ...

Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...

insights from industryAmy ShengHead of CROSino Biological In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO program at Sino Biological US Inc., about current developments in the ...